Product Information
INVOKAMET 150-500 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $9.6089 per EA under NDC 50458054260. Its NADAC has been published 571 times since Mar 18, 2015.
FDA first approved this application on Aug 8, 2014.
Strength
150; 500 mg/1; mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458054260
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA204353FDA Approved
8/8/2014
On Market Since
8/8/2014
Pharmacological Classes
Price Statistics
The NADAC for INVOKAMET 150-500 MG TABLET has been published 571 times since Mar 18, 2015, and over the history we have for it it has risen 74.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.6089 per EA |
|---|---|
| All-time high | $9.6197 (Jul 15, 2026) |
| All-time low | $5.4866 (Apr 22, 2015) |
| 52-week high | $9.6197 |
| 52-week low | $9.5328 |
| Median price | $8.3348 |
| Average price | $8.1250 |
| Largest weekly change | +8.9% (Jan 10, 2018) |
| Weeks tracked | 571 |
| Tracking since | Mar 18, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INVOKAMET 150-500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INVOKAMET 150-500 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $9.6089 per EA (NDC 50458054260), effective Aug 19, 2026.
How has the price of INVOKAMET 150-500 MG TABLET changed over time?
Over the history we have for it, the NADAC for INVOKAMET 150-500 MG TABLET has risen 74.6%. It has been tracked across 571 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for INVOKAMET 150-500 MG TABLET?
Since Mar 18, 2015, the NADAC for INVOKAMET 150-500 MG TABLET has ranged from a low of $5.4866 (Apr 22, 2015) to a high of $9.6197 (Jul 15, 2026), with a median of $8.3348 per EA.
Are there cheaper alternatives to INVOKAMET 150-500 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INVOKAMET XR 150-500 MG TABLET, is $9.5612 per EA — about 0% below INVOKAMET 150-500 MG TABLET.
Who manufactures INVOKAMET 150-500 MG TABLET?
INVOKAMET 150-500 MG TABLET (NDC 50458054260) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.